Schedule 13D ownership disclosure

MATINAS BIOPHARMA HLDGS INC

COMMON STOCK, $0.0001 PAR VALUE PER SHARE · CUSIP: 576810303

Event date: 2025-09-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Hezbay Holdings LLCReported CIK 0002058272

    Shares: 253,841.00 · Class: 4.99%

  • Ari Kluger

    Shares: 253,841.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-091622
Form type
SCHEDULE 13D/A
Filer
Hezbay Holdings LLC
CIK
CIK 2058272
Filed
Sep 25, 2025
Reporting period
Sep 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub